Literature DB >> 26514579

Aerosolized Non-viral Nucleic Acid Delivery in the Vaginal Tract of Pigs.

Katrien Remaut1, Evelien De Clercq2, Oliwia Andries3, Koen Rombouts1, Matthias Van Gils2, Laetitia Cicchelero3, Ian Vandenbussche1, Sarah Van Praet1, Juan Manuel Benito4, José Manuel Garcia Fernandéz4, Niek Sanders3, Daisy Vanrompay5,6.   

Abstract

PURPOSE: The human pathogen Chlamydia trachomatis is worldwide the leading cause of bacterial sexually transmitted disease. Nasal or vaginal nucleic acid vaccination is a promising strategy for controlling genital Chlamydia trachomatis infections. Since naked nucleic acids are generally not efficiently taken up by cells, they are often complexed with carriers that facilitate their intracellular delivery.
METHODS: In the current study, we screened a variety of commonly used non-viral gene delivery carriers for their ability to transfect newborn pig tracheal cells. The effect of aerosolization on the physicochemical properties and transfection efficiency of the complexes was also evaluated in vitro. Subsequently, a pilot experiment was performed in which the selected complexes were aerosolized in the vaginal tract of pigs.
RESULTS: Both mRNA and pDNA containing lipofectamine and ADM70 complexes showed promise for protein expression in vitro, before and after aerosolization. In vivo, only lipofectamine/pDNA complexes resulted in high protein expression levels 24 h following aerosolization. This correlates to the unexpected observation that the presence of vaginal mucus increases the efficiency of lipofectamine/pDNA complexes 3-fold, while the efficiency of lipofectamine/mRNA complexes and ADM70/mRNA and ADM70/pDNA complexes decreased.
CONCLUSIONS: As aerosolization was an easy and effective method to deliver complexes to the vaginal tract of pigs, we believe this application technique has future potential for both vaginal and perhaps nasal vaccination using non-viral gene delivery vectors.

Entities:  

Keywords:  aerosolization; mRNA; non-viral gene delivery complexes; plasmid DNA; vaginal administration

Mesh:

Substances:

Year:  2015        PMID: 26514579     DOI: 10.1007/s11095-015-1796-x

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  39 in total

Review 1.  Intracellular partitioning of cell organelles and extraneous nanoparticles during mitosis.

Authors:  Nathalie Symens; Stefaan J Soenen; Joanna Rejman; Kevin Braeckmans; Stefaan C De Smedt; Katrien Remaut
Journal:  Adv Drug Deliv Rev       Date:  2011-12-02       Impact factor: 15.470

2.  Innate immune response and programmed cell death following carrier-mediated delivery of unmodified mRNA to respiratory cells.

Authors:  Oliwia Andries; Marina De Filette; Stefaan C De Smedt; Jo Demeester; Mario Van Poucke; Luc Peelman; Niek N Sanders
Journal:  J Control Release       Date:  2013-02-08       Impact factor: 9.776

3.  Peptide-mediated RNA delivery: a novel approach for enhanced transfection of primary and post-mitotic cells.

Authors:  T Bettinger; R C Carlisle; M L Read; M Ogris; L W Seymour
Journal:  Nucleic Acids Res       Date:  2001-09-15       Impact factor: 16.971

4.  High efficiency transformation by direct microinjection of DNA into cultured mammalian cells.

Authors:  M R Capecchi
Journal:  Cell       Date:  1980-11       Impact factor: 41.582

Review 5.  Antiviral immune responses in the genital tract: clues for vaccines.

Authors:  Akiko Iwasaki
Journal:  Nat Rev Immunol       Date:  2010-09-10       Impact factor: 53.106

6.  Cellular and molecular barriers to gene transfer by a cationic lipid.

Authors:  J Zabner; A J Fasbender; T Moninger; K A Poellinger; M J Welsh
Journal:  J Biol Chem       Date:  1995-08-11       Impact factor: 5.157

Review 7.  Cancer immunotherapy with mRNA-transfected dendritic cells.

Authors:  Eli Gilboa; Johannes Vieweg
Journal:  Immunol Rev       Date:  2004-06       Impact factor: 12.988

Review 8.  RNA: the new revolution in nucleic acid vaccines.

Authors:  Andrew J Geall; Christian W Mandl; Jeffrey B Ulmer
Journal:  Semin Immunol       Date:  2013-06-02       Impact factor: 11.130

9.  Pelvic inflammatory disease and fertility. A cohort study of 1,844 women with laparoscopically verified disease and 657 control women with normal laparoscopic results.

Authors:  L Weström; R Joesoef; G Reynolds; A Hagdu; S E Thompson
Journal:  Sex Transm Dis       Date:  1992 Jul-Aug       Impact factor: 2.830

10.  Establishment and characterization of two new pig cell lines for use in virological diagnostic laboratories.

Authors:  M Ferrari; A Scalvini; M N Losio; A Corradi; M Soncini; E Bignotti; E Milanesi; P Ajmone-Marsan; S Barlati; D Bellotti; M Tonelli
Journal:  J Virol Methods       Date:  2003-02       Impact factor: 2.014

View more
  4 in total

1.  An effective vaginal gel to deliver CRISPR/Cas9 system encapsulated in poly (β-amino ester) nanoparticles for vaginal gene therapy.

Authors:  Gang Niu; Zhuang Jin; Chong Zhang; Dan He; Xueqin Gao; Chenming Zou; Wei Zhang; Jiahui Ding; Bhudev C Das; Konstantin Severinov; Inga Isabel Hitzeroth; Priya Ranjan Debata; Xin Ma; Xun Tian; Qinglei Gao; Jun Wu; Zeshan You; Rui Tian; Zifeng Cui; Weiwen Fan; Weiling Xie; Zhaoyue Huang; Chen Cao; Wei Xu; Hongxian Xie; Hongyan Xu; Xiongzhi Tang; Yan Wang; Zhiying Yu; Hui Han; Songwei Tan; Shuqin Chen; Zheng Hu
Journal:  EBioMedicine       Date:  2020-07-22       Impact factor: 8.143

2.  DNA prime-protein boost vaccine encoding HLA-A2, HLA-A24 and HLA-DR1 restricted epitopes of CaNA2 against visceral leishmaniasis.

Authors:  Jinlei He; Fan Huang; Jianhui Zhang; Han Chen; Qiwei Chen; Junrong Zhang; Jiao Li; Zhiwan Zheng; Dali Chen; Jianping Chen
Journal:  Immunology       Date:  2018-10-24       Impact factor: 7.397

Review 3.  Gene delivery based on macrocyclic amphiphiles.

Authors:  Wen-Chao Geng; Qiaoxian Huang; Zhe Xu; Ruibing Wang; Dong-Sheng Guo
Journal:  Theranostics       Date:  2019-05-18       Impact factor: 11.556

Review 4.  Engineering monoclonal antibody-based contraception and multipurpose prevention technologies†.

Authors:  Deborah J Anderson; Joseph A Politch; Richard A Cone; Larry Zeitlin; Samuel K Lai; Philip J Santangelo; Thomas R Moench; Kevin J Whaley
Journal:  Biol Reprod       Date:  2020-08-04       Impact factor: 4.161

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.